With an ecosystem of high-throughput instruments generating multi-terabyte datasets, the data management capacity of a leading global gene therapy innovator had reached breaking point. It was too slow ...
When the US Food and Drug Administration (FDA) approved benzgalantamine (Zunveyl) in July 2024 for Alzheimer’s disease, it ...
Get the latest Sai Life Sciences share price today on NSE & BSE. Explore Sai Life Sciences stock analysis, financial performance, market capitalization, dividend history, and future outlook for ...
Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results